Stock ENZON PHARMACEUTICALS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company Enzon Pharmaceuticals Inc Nasdaq

Equities

US2939041081

Biotechnology & Medical Research

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Enzon Pharmaceuticals Inc
Mar. 20 Enzon Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Enzon Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Business Summary

Enzon Pharmaceuticals, Inc. (Enzon) is an acquisition vehicle company. The Company intends to become an acquisition platform. The Company utilizes its net operating loss carryforwards (NOLs) and improves stockholder value. It manages its source of royalty revenues from existing licensing arrangements with other companies.

Managers

Managers TitleAgeSince
Richard L. Feinstein CEO
 Chief Executive Officer 80 13-12-12

Members of the board

Members of the board TitleAgeSince
Randolph Read CHM
 Chairman 71 20-08-03
Jaffrey Adam Firestone BRD
 Director/Board Member 67 22-06-30
Jordan Bleznick BRD
 Director/Board Member 68 20-08-03

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 74,214,603 66,170,649 ( 89.16 %) 0 89.16 %

Shareholders

NameEquities%Valuation
Icahn Associates Holding LLC
48.58 %
36,056,636 48.58 % 3 M $
Jonathan Couchman
9.581 %
7,110,690 9.581 % 547 523 $
OrbiMed Advisors LLC
1.617 %
1,200,000 1.617 % 92 400 $
MYREXIS, INC.
0.8533 %
633,264 0.8533 % 48 761 $
Oppenheim Fonds Trust GmbH
0.5049 %
374,700 0.5049 % 28 852 $
Randolph Read
0.2695 %
200,000 0.2695 % 15 400 $
Jordan Bleznick
0.1347 %
100,000 0.1347 % 7 700 $
Merrill Lynch Investment Managers, Inc.
0.0740 %
54,900 0.0740 % 4 227 $
Medical Strategy GmbH
0.0509 %
37,800 0.0509 % 2 911 $
Sella SGR SpA
0.0230 %
17,100 0.0230 % 1 317 $

Company contact information

Enzon Pharmaceuticals, Inc.

20 Commerce Drive Suite 135

07016, Cranford

+732 980 4500

http://www.enzon.com
address Enzon Pharmaceuticals Inc

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Sector Bio Therapeutic Drugs

1st Jan change Capi.
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-2.31% 103B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+0.56% 95.28B
ARGENX SE Stock argenx SE
+0.52% 22.15B
BIONTECH SE Stock BioNTech SE
-17.37% 21.02B
GENMAB A/S Stock Genmab A/S
-8.98% 18.15B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-41.01% 16.73B
BEIGENE, LTD. Stock BeiGene, Ltd.
-14.85% 16.05B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+3.21% 13.68B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+33.54% 12.17B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. ENZN Stock
  4. Stock
  5. Company Enzon Pharmaceuticals Inc